Novo Nordisk
NVO
#109
Rank
C$236.83 B
Marketcap
C$53.24
Share price
-1.07%
Change (1 day)
-34.09%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report